Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | +2.19% | -3.78% | -23.64% |
04-30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
03-27 | North American Morning Briefing : Stocks Edge -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.64% | 36.63M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Oppenheimer Adjusts Marker Therapeutics' Price Target to $5 From $8, Maintains Outperform Rating